Browse > Article
http://dx.doi.org/10.3345/kjp.2007.50.12.1241

Influence of vascular endothelial growth factor (VEGF) and endostatin on coronary artery lesions in Kawasaki disease  

Kim, Seon A (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Jung, Bum Suk (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Yoon, Jong Seo (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Han, Ji Whan (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Joon Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.12, 2007 , pp. 1241-1246 More about this Journal
Abstract
Purpose : Recently, there has been several studies to clarify the pathogenesis of Kawasaki disease (KD) and the relations of VEGF and endostatin that act on vascular endothelial cells to the coronary artery complications. In this report, we measured serum levels of VEGF and endostatin in acute and subacute phases of KD to assess the change of these levels and the relations to the development of coronary artery lesions (CAL). Methods : Twenty six patients were diagnosed and treated for KD between January, 2001 and July, 2005 at Kangnam St. Mary's Hospital, the Catholic University of Korea. They were divided into those with and without CAL. Serum levels of VEGF and endostatin were measured during acute and subacute phases and compared to those measured in healthy and disease control groups. Results : Serum levels of VEGF were increased in KD but no differences were noted in KD with and without CAL. Serum levels of endostatin were decreased in the acute phase of KD, however they were recovered in the subacute phase of KD, regardless of CAL. The VEGF/endostatin ratio was increased in KD. KD without CAL showed a relative decrease in this ratio during the subacute phase. Significant positive correlations were found between serum VEGF and WBC count, VEGF and ESR, VEGF/endostatin ratio and ESR in the acute phase of KD. Conclusion : Analysis of factors influencing the vascular endothelium such as VEGF and endostatin will help to clarify the etiology of KD and the pathogenesis of CAL.
Keywords
Kawasaki disease; Vascular endothelial growth factor; Endostatin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim DS. Kawasaki disease. Yonsei Med J 2006;47:759-72   DOI   ScienceOn
2 Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 2006;74:1141-8
3 Schroh AM, Dominguez P, Laghezza LB, Melonari PA, Olguin M, Miatello R. Kawasaki disease: heart disease during childhood. Rev Esp Cardiol 2006;59:387-90   DOI   ScienceOn
4 Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial grow th factor in Kawasaki disease. Pediatr Res 1998;44: 596-9   DOI   ScienceOn
5 Park MH, Jung HL, Yang JH, Shim JY, Kim DS, Shim JW, et al. Serum vascular endothelial growth factor as a predictive risk factor for the occurrence of coronary artery lesions in Kawasaki disease. J Korean Pediatr Soc 2003;46: 811-6
6 Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clin Exp Immunol 2005;139:575-9   DOI   ScienceOn
7 Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independentl zinc binding. EMBO J 1999;18:4414-23   DOI   ScienceOn
8 Ohno T, Yuge T, Kariyazono H, Igarashi H, Joh-o K, Kinugawa N, et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002;161:105-11   DOI
9 Kim MS, Kim KS. The study of serum vascular endothelial growth factor in the acute febrile phase of Kawasaki disease. J Korean Pediatr Soc 2002;45:114-9
10 Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47:232-4   DOI   ScienceOn
11 Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004;16:508-14   DOI   ScienceOn
12 Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999;83:337-9   DOI   ScienceOn
13 asukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002;105:766-9   DOI   ScienceOn
14 Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, et al. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 2003;63:8345-50
15 Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-9   DOI
16 Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004;56:953-9   DOI   ScienceOn
17 Royle J, Burgner D, Curtis N. The diagnosis and management of Kawasaki disease. J Paediatr Child Health 2005;41: 87-93   DOI   ScienceOn
18 Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 2000;101:2935-41   DOI   ScienceOn
19 Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998;41:1538-47   DOI   ScienceOn
20 Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan : Ministry of Health and Welfare, 1984
21 Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Ha moto I, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 2001;49:74-80   DOI   ScienceOn
22 Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20   DOI